WSA
ABBV icon

Warm Springs Advisors’s AbbVie ABBV Stock Holding History

Warm Springs Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.89M Sell
8,687
-27
-0.3% -$5.99K 1.6% 20
2025
Q4 		$1.99M Sell
8,714
-1,318
-13% -$300K 1.54% 23
2025
Q3 		$2.32M Buy
10,032
+87
+0.9% +$17.7K 1.76% 19
2025
Q2 		$1.85M Sell
9,945
-398
-4% -$74K 1.58% 21
2025
Q1 		$2.17M Sell
10,343
-1,252
-11% -$243K 2.18% 16
2024
Q4 		$2.06M Buy
+11,595
New +$2.13M 1.91% 15

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Warm Springs Advisors's ABBV Position: Q1 2026 in Review

Warm Springs Advisors reduced its AbbVie (ABBV) stake by 0.31% in Q1 2026, selling an estimated $5.99K and leaving 8,687 shares worth $1.89M. The position accounts for 1.6% of the portfolio, ranked #20.

Warm Springs Advisors first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.32M in Q3 2025. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Warm Springs Advisors held 8,687 shares of AbbVie worth $1.89M as of Q1 2026.
  • Warm Springs Advisors sold 27 AbbVie shares in Q1 2026, an estimated $5.99K.
  • AbbVie made up 1.6% of Warm Springs Advisors's portfolio in Q1 2026, its #20 holding.
  • Warm Springs Advisors first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Warm Springs Advisors's AbbVie position peaked at $2.32M in Q3 2025.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Warm Springs Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.